World glaucoma congress 2009

Research output: Contribution to journalArticle

Abstract

Glaucoma continues to pose a serious threat for the aging population, and can have a significant impact on the quality of life of the affected individuals. In addition, the prevalence of the disease is likely to increase as the worldwide older demographic increases. The majority of patients affected by glaucoma are still undiagnosed, particularly in underdeveloped countries. Advances in imaging technology are likely to provide further insight on the pathophysiology of the disease, and will allow new and more effective treatment modalities. Because glaucoma is a slowly progressing optic neuropathy, the detection of glaucomatous change continues to be a critical component in the management of the disease. Although the only treatment available for glaucoma is aimed at reducing IOP, recent advances in gene therapy and drug delivery may offer valid alternatives in the treatment of the disease in the future.

Original languageEnglish (US)
Pages (from-to)555-557
Number of pages3
JournalIDrugs
Volume12
Issue number9
StatePublished - Sep 2009
Externally publishedYes

Fingerprint

Glaucoma
Optic Nerve Diseases
Disease Management
Genetic Therapy
Therapeutics
Quality of Life
Demography
Technology
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

World glaucoma congress 2009. / Vizzeri, Gianmarco.

In: IDrugs, Vol. 12, No. 9, 09.2009, p. 555-557.

Research output: Contribution to journalArticle

Vizzeri, G 2009, 'World glaucoma congress 2009', IDrugs, vol. 12, no. 9, pp. 555-557.
Vizzeri G. World glaucoma congress 2009. IDrugs. 2009 Sep;12(9):555-557.
Vizzeri, Gianmarco. / World glaucoma congress 2009. In: IDrugs. 2009 ; Vol. 12, No. 9. pp. 555-557.
@article{011322d8a0434810945aa5b506b91327,
title = "World glaucoma congress 2009",
abstract = "Glaucoma continues to pose a serious threat for the aging population, and can have a significant impact on the quality of life of the affected individuals. In addition, the prevalence of the disease is likely to increase as the worldwide older demographic increases. The majority of patients affected by glaucoma are still undiagnosed, particularly in underdeveloped countries. Advances in imaging technology are likely to provide further insight on the pathophysiology of the disease, and will allow new and more effective treatment modalities. Because glaucoma is a slowly progressing optic neuropathy, the detection of glaucomatous change continues to be a critical component in the management of the disease. Although the only treatment available for glaucoma is aimed at reducing IOP, recent advances in gene therapy and drug delivery may offer valid alternatives in the treatment of the disease in the future.",
author = "Gianmarco Vizzeri",
year = "2009",
month = "9",
language = "English (US)",
volume = "12",
pages = "555--557",
journal = "IDrugs : the investigational drugs journal",
issn = "1369-7056",
publisher = "Current Drugs Ltd.",
number = "9",

}

TY - JOUR

T1 - World glaucoma congress 2009

AU - Vizzeri, Gianmarco

PY - 2009/9

Y1 - 2009/9

N2 - Glaucoma continues to pose a serious threat for the aging population, and can have a significant impact on the quality of life of the affected individuals. In addition, the prevalence of the disease is likely to increase as the worldwide older demographic increases. The majority of patients affected by glaucoma are still undiagnosed, particularly in underdeveloped countries. Advances in imaging technology are likely to provide further insight on the pathophysiology of the disease, and will allow new and more effective treatment modalities. Because glaucoma is a slowly progressing optic neuropathy, the detection of glaucomatous change continues to be a critical component in the management of the disease. Although the only treatment available for glaucoma is aimed at reducing IOP, recent advances in gene therapy and drug delivery may offer valid alternatives in the treatment of the disease in the future.

AB - Glaucoma continues to pose a serious threat for the aging population, and can have a significant impact on the quality of life of the affected individuals. In addition, the prevalence of the disease is likely to increase as the worldwide older demographic increases. The majority of patients affected by glaucoma are still undiagnosed, particularly in underdeveloped countries. Advances in imaging technology are likely to provide further insight on the pathophysiology of the disease, and will allow new and more effective treatment modalities. Because glaucoma is a slowly progressing optic neuropathy, the detection of glaucomatous change continues to be a critical component in the management of the disease. Although the only treatment available for glaucoma is aimed at reducing IOP, recent advances in gene therapy and drug delivery may offer valid alternatives in the treatment of the disease in the future.

UR - http://www.scopus.com/inward/record.url?scp=69249137473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249137473&partnerID=8YFLogxK

M3 - Article

C2 - 19697273

AN - SCOPUS:69249137473

VL - 12

SP - 555

EP - 557

JO - IDrugs : the investigational drugs journal

JF - IDrugs : the investigational drugs journal

SN - 1369-7056

IS - 9

ER -